About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Breast Cancer Clinical Trials in Portland | 441 Studies

Clinical Trials Breast CancerPortland

Breast Cancer Clinical Trials in Portland

Find 441 clinical trials for breast cancer near Portland, Oregon. Connect with research centers in your area.

All Breast Cancer trials nationwide All trials in Portland

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 321-340 of 441 trials

CompletedFour Versus Six Cycles of Cyclophosphamide/Doxorubicin or Paclitaxel in Adjuvant Breast CancerThis randomized phase III trial studies cyclophosphamide and doxorubicin hydrochloride compared with paclitaxel as adjuvant therapy in treating breast cancer in women with 0-3…NCT00041119·Anniston, Alabama and 526 others

Breast Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

TerminatedA Safety Study of SGN-CD47M in Patients With Solid TumorsThis trial will study SGN-CD47M to find out whether it is an effective treatment for different types of solid tumors and what side effects (unwanted effects) may occur.NCT03957096·Cleveland, Ohio and 4 others

CompletedA Study of Trastuzumab Emtansine in Comparison With Treatment of Physician's Choice in Participants With HER2-positive Breast Cancer Who Have Received at Least Two Prior Regimens of HER2-directed TherapyThis randomized, multicenter, 2-arm, open-label study (TH3RESA) will evaluate the efficacy and safety of trastuzumab emtansine (T-DM1) in comparison with treatment of the…NCT01419197·Tucson, Arizona and 183 others

CompletedPaclitaxel, Nab-paclitaxel, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast CancerThis randomized phase III trial studies the side effects and how well different chemotherapy regimens with or without bevacizumab work in treating patients with stage IIIC or…NCT00785291·Scottsdale, Arizona and 703 others

CompletedCAB-ROR2-ADC Safety and Efficacy Study in Patients With TNBC or Head & Neck Cancer (Ph1) and NSCLC or Melanoma (Ph2)The objective of this study is to assess safety and efficacy of CAB-ROR2-ADC in solid tumorsNCT03504488·Tucson, Arizona and 58 others

TerminatedBevacizumab in Treating Patients With Metastatic Breast Cancer That Overexpresses HER-2/NEUThis randomized phase III trial studies first-line chemotherapy and trastuzumab to compare how well they work when given with or without bevacizumab in treating patients with…NCT00520975·Jonesboro, Arkansas and 372 others

Active not recruitingRadiation Therapy With or Without Olaparib in Treating Patients With Inflammatory Breast CancerThis phase II trial studies how well radiation therapy with or without olaparib works in treating patients with inflammatory breast cancer.NCT03598257·Anchorage, Alaska and 219 others

CompletedThe BEACON Study (Breast Cancer Outcomes With NKTR-102)The study is designed as an open-label, randomized, parallel, two arm, multicenter, international Phase 3 study in patients with recurrent or metastatic breast cancer previously…NCT01492101·Flagstaff, Arizona and 152 others

TerminatedStudy of ADCT-301 in Patients With Selected Advanced Solid TumorsThis study evaluates ADCT-301 in patients with Selected Advanced Solid Tumors.NCT03621982·Palo Alto, California and 8 others

CompletedTherapy With Bevacizumab (BEV), Epirubicin, and Cyclophosphamide Followed by Docetaxel Plus Trastuzumab and BEV Given as Neoadjuvant or Adjuvant Therapy for Women With Locally Advanced HER2 Positive Invasive Breast CancerThe main purpose is to learn if adding bevacizumab to standard chemotherapy and trastuzumab to treat HER2-positive breast cancer will affect heart function.NCT00464646·Huntsville, Alabama and 35 others

TerminatedSerial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME TrialThis phase Ib trial determines if samples from a patient's cancer can be tested to find combinations of drugs that provide clinical benefit for the kind of cancer the patient has.NCT03878524·Portland, Oregon

Active not recruitingStandard or Comprehensive Radiation Therapy in Treating Patients With Early-Stage Breast Cancer Previously Treated With Chemotherapy and SurgeryThis randomized phase III trial studies standard or comprehensive radiation therapy in treating patients with early-stage breast cancer who have undergone surgery.NCT01872975·Birmingham, Alabama and 513 others

CompletedIncidence of Cancer in Women at Increased Genetic Risk of Ovarian CancerThis clinical trial is studying the incidence of cancer in women at increased genetic risk of ovarian cancer.NCT01139957·Birmingham, Alabama and 140 others

CompletedS0215 Trastuzumab, Docetaxel, Vinorelbine, and Filgrastim in Treating Women With Stage IV Breast CancerRATIONALE: Drugs used in chemotherapy work in different ways to stop tumor cells from dividing so they stop growing or die.NCT00041067·Mobile, Alabama and 144 others

CompletedPenguin Cold Caps in the Prevention of Hair Loss in Breast Cancer PatientsThe goal of this study is to estimate the efficacy of Penguin cold caps in preventing or reducing hair loss in patients receiving (neo)adjuvant chemotherapy (one of four common…NCT03289364·Portland, Oregon

Active not recruitingPhase I-II, FIH, TROP2 ADC, Advanced Unresectable/Metastatic Solid Tumors, Refractory to Standard Therapies (KL264-01)A Phase I-II, First-in-Human Study of SKB264 (Sac-TMT; MK-2870) in Patients with Locally Advanced Unresectable/Metastatic Solid Tumors who are refractory to Available Standard…NCT04152499·Glendale, California and 108 others

CompletedGlycan Mediated Immune Regulation With a Bi-Sialidase Fusion Protein (GLIMMER-01)This is a Phase 1/2, first-in-human, open-label, dose escalation and dose-expansion study of E-602, administered alone and in combination with cemiplimab.NCT05259696·La Jolla, California and 12 others

TerminatedA Safety Study of SGN-2FF for Patients With Advanced Solid TumorsThis study is being done to find out the side effects (unwanted effects) that are caused in patients with cancers who are given SGN-2FF.NCT02952989·Birmingham, Alabama and 10 others

RecruitingS1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast CancerThis randomized research trial studies how well serum tumor marker directed disease monitoring works in monitoring patients with hormone receptor positive Her2 negative breast…NCT03723928·Anchorage, Alaska and 722 others

Active not recruitingAxillary Reverse Mapping in Preventing Lymphedema in Patients With Breast Cancer Undergoing Axillary Lymph Node DissectionThis phase III trial studies how well axillary reverse mapping works in preventing lymphedema in patients with breast cancer undergoing axillary lymph node dissection.NCT03927027·Little Rock, Arkansas and 95 others

PreviousPage 17 of 23Next

Other Conditions in Portland

Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma